These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20207034)

  • 1. Ultrafiltration does not affect certain predictors of outcome in heart failure.
    Kazory A
    Int J Cardiol; 2010 Aug; 143(1):1-3. PubMed ID: 20207034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltration for decompensated heart failure: renal implications.
    Kazory A; Ross EA
    Heart; 2009 Jul; 95(13):1047-51. PubMed ID: 19261603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Med; 2004 Apr; 116(7):466-73. PubMed ID: 15047036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration in heart failure.
    Fiaccadori E; Regolisti G; Maggiore U; Parenti E; Cremaschi E; Detrenis S; Caiazza A; Cabassi A
    Am Heart J; 2011 Mar; 161(3):439-49. PubMed ID: 21392597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafiltration in acute decompensated heart failure: friend or foe for the kidney?
    Regolisti G; Fiaccadori E
    J Nephrol; 2013; 26(3):421-6. PubMed ID: 23661589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration in the management of heart failure.
    Costanzo MR
    Curr Opin Crit Care; 2008 Oct; 14(5):524-30. PubMed ID: 18787444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-pharmacological therapy of decompensated heart failure: the extracorporeal ultrafiltration].
    Tovena DM; Pedrinazzi C; Ogliari V; De Petri G; Mileti M; Inama G
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):118S-122S. PubMed ID: 19195319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous renal replacement therapy for congestive heart failure: the wearable continuous ultrafiltration system.
    Gura V; Beizai M; Ezon C; Rambod E
    ASAIO J; 2006; 52(1):59-61. PubMed ID: 16436891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device therapy in the management of congestive heart failure.
    Turer AT; Rao SV
    Cardiol Rev; 2005; 13(3):130-8. PubMed ID: 15831146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peripheral ultrafiltration in the management of acute decompensated heart failure.
    Andrade JG; Stadnick E; Virani SA
    Blood Purif; 2010; 29(2):177-82. PubMed ID: 20093824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafiltration for congestive heart failure.
    Thorsgard M; Bart BA
    Congest Heart Fail; 2009; 15(3):136-43. PubMed ID: 19522963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.
    Jaski BE; Romeo A; Ortiz B; Hoagland PM; Stone M; Glaser D; Thomas L; Walsh C; Smith SC
    J Card Fail; 2008 Aug; 14(6):515-20. PubMed ID: 18672200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.
    Bart BA; Boyle A; Bank AJ; Anand I; Olivari MT; Kraemer M; Mackedanz S; Sobotka PA; Schollmeyer M; Goldsmith SR
    J Am Coll Cardiol; 2005 Dec; 46(11):2043-6. PubMed ID: 16325039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating aquapheresis into the hospital setting: a practical approach.
    Peterangelo M
    Prog Cardiovasc Nurs; 2008; 23(4):168-72. PubMed ID: 19067980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Need for a unified decision-making tool for ultrafiltration therapy in heart failure; call for action.
    Kazory A
    Am Heart J; 2010 Apr; 159(4):505-7. PubMed ID: 20362706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
    Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.